CClinicalTrials.gg
RecruitingNCT01158482FILTERUpdated Sep 26, 2025

Filter Initial & Long Term Evaluation After Placement and Retrieval Registry

An observational study in Venous Thromboembolism, sponsored by Stanford University. Recruiting at 1 site in United States. Per ClinicalTrials.gov, last updated 2025-09-26.

Sponsored by Stanford University · Observational

Study type
Observational
Model
Case-only
Time perspective
Prospective
Enrollment
5,000
Sex
All
01

Study summary

A prospective data registry for all patients who undergo IVC (Inferior Vena Cava) filter placement or retrieval at Stanford. Potential enrollees will already be undergoing the procedure. If patients are willing, they will be prospectively enrolled prior to the procedure. As part of the study, chart and clinical data reviews will be used to track patient progress and response to the treatment.

Read the detailed description

Patient clinical data will be used in a clinical registry. Before a patient is to undergo their initial procedure for filter placement/retrieval, we will approach them for consent to participate in the study. If patients consent, we will follow clinical data from the procedure, and perform prospective follow-up over time to track clinical response and effects of the placement or removal procedure.

Various real-world protocols involving advanced filter removal (including laser-assisted filter removal) will be investigated by conducting registry-based clinical trials.

Participants will only be enrolled if they will be undergoing an IVC (Inferior Vena Cava) filter placement/retrieval procedure.

02

Conditions studied

  • Venous Thromboembolism
03

In context

Venous Thromboembolism

694 studies on the registry are indexed under Venous Thromboembolism; 152 are open to participants now.

This study's planned enrollment of 5,000 is above the median of 700 across 283 observational studies indexed under Venous Thromboembolism.

Browse Venous Thromboembolism studies →

Lead sponsor

Stanford University is the lead sponsor of 2,117 studies on the registry; 425 are open to participants now.

Of its 259 completed or terminated interventional studies of FDA-regulated products, 197 (76%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

No specific criteria. Anyone who will be undergoing IVC Filter Placement/Retrieval will be eligible.

Inclusion criteria

  • Participants are adults, 18 years old or older
  • Participants will be undergoing a procedure to have an IVC filter placed or removed

Exclusion criteria

Exclusion Criteria:

None

05

Study design

Observational model
Case-only
Time perspective
Prospective
Enrollment
5,000 participants (estimated)
Patient registry
No

Groups and cohorts

  • IVC Filter Placement or Removal

    Patients undergoing IVC filter placement and/or IVC filter removal at Stanford Medical Center.

    Procedure: IVC Filter Placement or Retrieval

Interventions

  • ProcedureIVC Filter Placement or Retrieval

    An IVC Filter will be placed or removed using endovascular techniques.

06

Study locations

1 of 1 sites recruiting
  • Stanford University School of Medicine
    Stanford, California 94305, United States
    • William Kuo · Contact · wkuo@stanford.edu · 650-724-7362
    • William T Kuo MD · Principal investigator
    • Dr. Lawrence (Rusty) Hofmann MD · Sub investigator
    • Daniel Yung-Ho Sze · Sub investigator
    • David Hovsepian · Sub investigator
    • Nishita N. Kothary · Sub investigator
    • Dr. John D Louie · Sub investigator
    • Gloria Hwang · Sub investigator
    Recruiting
07

References and documents

Publications

  • Kuo WT, Doshi AA, Ponting JM, Rosenberg JK, Liang T, Hofmann LV. Laser-Assisted Removal of Embedded Vena Cava Filters: A First-In-Human Escalation Trial in 500 Patients Refractory to High-Force Retrieval. J Am Heart Assoc. 2020 Dec 15;9(24):e017916. doi: 10.1161/JAHA.119.017916. Epub 2020 Nov 30. PubMed 33252283 ↗
  • Sheu AY, Hoang NS, Kesselman AJ, Liang T, Rosenberg JK, Kuo WT. Prophylactic IVC filter placement in bariatric surgery patients: results from a prospective filter registry. CVIR Endovasc. 2018;1(1):13. doi: 10.1186/s42155-018-0021-5. Epub 2018 Nov 15. PubMed 30652145 ↗
  • Kuo WT, Odegaard JI, Rosenberg JK, Hofmann LV. Laser-Assisted Removal of Embedded Vena Cava Filters: A 5-Year First-in-Human Study. Chest. 2017 Feb;151(2):417-424. doi: 10.1016/j.chest.2016.09.029. Epub 2016 Oct 8. PubMed 27729265 ↗
  • Kuo WT, Odegaard JI, Rosenberg JK, Hofmann LV. Excimer laser-assisted removal of embedded inferior vena cava filters: a single-center prospective study. Circ Cardiovasc Interv. 2013 Oct 1;6(5):560-6. doi: 10.1161/CIRCINTERVENTIONS.113.000665. Epub 2013 Sep 24. PubMed 24065445 ↗
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 26, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT01158482
Lead sponsor
Stanford University
Responsible party
William Kuo (M.D., Stanford University) — Principal investigator
First posted
Jul 8, 2010
Start date
Jun 2010
Primary completion
Jun 2027 (estimated)
Completion
Jun 2030 (estimated)
Last update
Sep 26, 2025

Study contacts

William Kuo
Contact
wkuo@stanford.edu
(650) 724-7362
William T Kuo MD
principal investigator · Stanford University

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion